The Marlborough, MA-based company presented its plan for success at the 38th annual J.P. Morgan Healthcare Conference, announcing it would pursue more tuck-in deals and invest in share buybacks. The plans come a few weeks after Hologic’s divested the Cynosure medical aesthetics business, which had been underperforming.